
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
Investing.com - AstraZeneca (NASDAQ:AZN) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca announced earnings per share of...
AstraZeneca Plc's (NASDAQ: NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion...
AstraZeneca (NASDAQ:AZN) reported Q1 EPS of $1.89, $1.06 better than the analyst estimate of $0.83. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $10.99...
Investing.com - AstraZeneca (NASDAQ:AZN) ADR reported on Friday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. AstraZeneca ADR announced earnings per...
By Laura Sanchez Investing.com - Today, investors focus on important macro data, such as eurozone inflation and GDP in different European countries. We will also keep an eye on the corporate earnings...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Uranium Energy Corp. (NYSE: UEC) is a "very speculative stock." He added that the stock had a very big run and might get "cut in half or...
Investing.com – U.K. equities were lower at the close on Thursday, as losses in the Automobiles & Parts, Household Goods & Home Construction and Life Insurance/Assurance sectors propelled shares...
(Reuters) - AstraZeneca (NASDAQ:AZN) said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the...
By Pushkala Aripaka (Reuters) -Britain's medicines regulator has approved AstraZeneca (NASDAQ:AZN)'s antibody-based COVID-19 treatment for preventing infections in adults with poor immune response,...
(Reuters) -AstraZeneca Plc has agreed to develop an antibody-based therapy with Swiss biotechnology firm Neurimmune for a rare, underdiagnosed condition that can lead to heart failure in a deal...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review